Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-04

Clinical Trial Update: Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial results for etanercept in the treatment of psoriasis, with the study status reported as completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2010-05-04